MN rgp160 AIDS vaccine: Started Phase I/II U.S. trial

Immuno-U.S. Inc. Product: MN rgp160 AIDS vaccine, with and without a priming vaccination of HIVAC-1e, a live vaccinia vector vaccine Indication: HIV-negative volunteers Status: Started Phase I/II U.S....